In this article

Noom Med combines medical care with a behavior-change app, while a standard Noom subscription is a different purchase. If you are searching for a weight-loss medication alternative, first identify which service and prescription pathway you currently use.

The current Noom Med page describes both direct-access and insurance-related starting offers. This comparison separates those offers from app-only pricing and compares the support tools that may matter when choosing another program.

THE SHORT ANSWER

Compare the actual medical pathway, medicine cost, and behavior-change services, and check for overlapping subscriptions. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.

What to know first

  • Compare the actual medical pathway, medicine cost, and behavior-change services, and check for overlapping subscriptions.
  • CoreAge Rx is the first listing through a disclosed commercial arrangement.
  • Confirm the proposed product, care arrangement, and complete written payment terms.

How this shortlist was selected

CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.

Compare the actual medical pathway, medicine cost, and behavior-change services, and check for overlapping subscriptions. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.

01. CoreAge Rx — featured partner

Our sponsored self-pay comparison for prescription care. We have not established an equivalent Noom behavior-change app here; compare any support you would need separately.

The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.

The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.

Continue with our CoreAge Rx review and pricing details.

02. WeightWatchers Med+ (Clinic)

A medical-plus-behavioral comparison through Med+. Separate its introductory membership, continuing commitment, and medication cost.

WeightWatchers Med+ advertises a $25 first membership month on a six- or 12-month plan. Subsequent membership is $84 per month on the six-month plan or $74 on the 12-month plan. GLP-1 medication costs are additional.

Check the full membership term and its automatic renewal. A medication promotion, a Med+ introductory charge, and insurance approval each have separate conditions.

Check the official WeightWatchers Med+ (Clinic) program page for the current offer and conditions. Our WeightWatchers Med+ (Clinic) alternatives comparison examines other care models.

03. Found

Offers insured and cash-pay arrangements with different consultation formats. Its prepaid and 28-day terms deserve a complete cost calculation.

Found advertises $99 for its insurance pathway and $169 for cash pay on 12-month prepaid plans, while describing billing in 28-day cycles. Its monthly-plan figures are $199 with insurance and $289 cash pay. Insurance visits can add copays; branded medication costs are separate.

Ask for the total upfront charge, number of covered 28-day cycles, medication, and visit copays. A low insured-plan headline is neither proof of drug coverage nor a complete branded-drug price.

Check the official Found program page for the current offer and conditions. Our Found alternatives comparison examines other care models.

04. Calibrate

A structured coaching-and-curriculum model with an initial membership commitment. Medication and labs are additional.

Calibrate lists membership at $199 per month with a three-month initial commitment: $597 paid in monthly installments. Lab tests and prescription medicines are excluded from that membership price.

Insurance assistance does not guarantee a covered prescription. Review the commitment, medication and lab costs, and the separate conditions attached to any advertised money-back offer.

Check the official Calibrate program page for the current offer and conditions. Our Calibrate alternatives comparison examines other care models.

05. Hello Alpha

A care membership describing appointment-free visits and approved medication pathways. It provides a different contact model, not a like-for-like replacement for Noom’s app.

Hello Alpha’s weight-loss page advertises Alpha Plus+ at $79 per month. Prescription costs depend on the product, pharmacy, and coverage; the membership price is not a complete GLP-1 medication bill.

Check the exact medicine and indication with the clinician. Membership does not guarantee a prescription, and insurance assistance does not guarantee approval or a refund if a prior authorization is denied.

Check the official Hello Alpha program page for the current offer and conditions. Our Hello Alpha alternatives comparison examines other care models.

06. Shapely

A comparison for recurring provider video visits and dietitian access. Confirm what individual support the selected membership includes and add the medicine cost.

Shapely lists a $49 first self-pay membership month followed by $99 per month. Medication is excluded, and the site separately lists medication starting prices and possible lab charges. Its insured pathway requires an individual coverage check.

Confirm which visits your plan covers and which services belong to the selected membership. Acceptance of an insurance plan does not establish coverage of a weight-loss prescription.

Check the official Shapely program page for the current offer and conditions. Our Shapely alternatives comparison examines other care models.

The current Noom Med baseline

The page advertises a direct-access GLP-1 pathway starting at $79 and an insurance-related pathway starting at $39 plus the patient’s medication cost. These describe different options; they should not be collapsed into one ongoing price.

Noom Med combines a medical-care pathway with the Noom behavior-change platform. Its current page includes several medication categories and describes clinician evaluation before any prescription. This is distinct from joining an app-only weight-management program.

Noom’s page says prescriptions may be coordinated through a pharmacy or shipped, depending on the program and circumstances. Ask for the assigned dispenser and exact product rather than assuming every Noom Med plan uses one pharmacy.

The details that decide this comparison

Ask whether the quoted plan is Noom Med and whether its direct-access or insurance-related pathway applies. The lowest figure from one pathway should not be combined with features from another.

Identify the app tools, coaching, or structured support you use regularly. A medication-only quote may not replace those services.

If you already subscribe to Noom, ask whether medical enrollment replaces or adds to that subscription. Repeat the question when leaving for another provider.

Keep the treatment distinction clear

An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.

Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.

Before you make a change

List the services you would keep if the medication provider changed: food tracking, coaching, clinician contact, and prescription access. Then price only the combination you actually plan to use.

If insurance is involved, confirm the next provider’s authorization process before assuming a covered prescription transfers automatically. Keep the app subscription decision separate from continuity of medical care.

Sources & research notes

Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

  1. CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
  2. CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
  3. CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
  4. CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
  5. CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
  6. WeightWatchers Med+ (Clinic): official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  7. Found: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  8. Calibrate: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  9. Hello Alpha: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  10. FDA: Wegovy semaglutide tablets, NDA 218316 approval letterRegulatory source · Checked September 21, 2026
  11. Shapely: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  12. Noom Med - GLP-1 Medications for Weight LossProvider-published information · Checked September 21, 2026
  13. Terms and Conditions of UseProvider-published information · Checked September 21, 2026
  14. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
  15. FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026

Read our methodology · Commercial disclosure · Request a correction